Stay updated on Clinical Trial Assessing IBI310 Similarity to Ipilimumab
Sign up to get notified when there's something new on the Clinical Trial Assessing IBI310 Similarity to Ipilimumab page.

Latest updates to the Clinical Trial Assessing IBI310 Similarity to Ipilimumab page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page has undergone a version update from v2.14.4 to v2.15.0, and the status of a previously listed item has changed from 'Active, not recruiting' to 'Completed'.SummaryDifference4%
- Check41 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check84 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check98 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check106 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
Stay in the know with updates to Clinical Trial Assessing IBI310 Similarity to Ipilimumab
Enter your email address, and we'll notify you when there's something new on the Clinical Trial Assessing IBI310 Similarity to Ipilimumab page.